Intubation Conditions With Atracurium After Three Minutes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-23

Study Completion Date

2021-09-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate intubation conditions with the use of atracurium after a fixed three-minute delay

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Residual Paralysis in Patients Who Receive Mini-dose Atracurium During Supraglottic Airway Insertion

NCT02673853

Postoperative Complications

COMPLETED

An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.

NCT04921735

Onset Time of Cisatracurium Duration of Action of Cisatracurium Intubation Conditions

COMPLETED

Study Evaluating the Efficacy and Safety of Remifentanil in a Rapid Sequence Induction for Fragile Subjects

NCT01259648

Tachycardia

COMPLETED PHASE4

Premedication Trial for Tracheal Intubation of the NEOnate

NCT01490580

Premedication Endotracheal Intubation

COMPLETED PHASE2/PHASE3

Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity

NCT00440102

Intubation; Difficult

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The recommended dose of a non-depolarizing curare to facilitate tracheal intubation is twice the active dose 95 (the dose that reduces muscle force by 95%). At this dosage, curarization of the laryngeal adductors allowing relaxation and abduction (opening) of the vocal cords is considered certain. With atracurium, the dose for intubation is 0.5 mg.kg-1 and the time to full effect is approximately 3 minutes. With the use of newer hypnotics, there are no data evaluating the conditions for intubation after a fixed time of 3 minutes as with current anesthetic practices.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Female Patients Require General Anaesthesia With Intubation and Atracurium Curarization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult female
* Patient to undergo general anesthesia with intubation for scheduled gynecological surgery
* Patient informed about the study and not opposed to it

Exclusion Criteria

* Patients with severe and morbid obesity (BMI\>35kg/m2)
* Pregnancy
* Patients with difficult intubation
* Allergy to atracurium and to any other drug used.
* Patient under tutorship / curatorship
* Not affiliated with social insurance
* Patient with AME

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No